XRAYS - Making Sense of Cancer Headlines

FORCE’s eXamining the Relevance of Articles for Young Survivors (XRAYS) program is a reliable resource for breast cancer research-related news and information. XRAYS reviews new breast cancer research, provides plain-language summaries, and rates how the media covered the topic. XRAYS is funded by the CDC.

XRAYS logo and women

Read the topic that we reviewed this week

PERSONAL STORY: Running marathons with metastatic breast cancer? Yes!

XRAYS Rating
XRAYS personal story

Runner’s World Magazine featured Sarah Smith, a metastatic breast cancer patient who runs marathons and ultra-marathons. By telling her story, Sarah wants to encourage people to stay active, despite the challenges that life may bring. (10/13/19)

Search for reviews by category, keyword or date or browse our recent articles below

Featured Studies and Articles

XRAYS Rating

STUDY: Study of the PARP inhibitor talazoparib (Talzenna) for early-stage breast cancer is promising

The PARP inhibitor talazoparib (Talzenna) has been useful for treatment of advanced or metastatic breast cancer for patients with BRCA mutations. A preliminary study showed that the majority of patients who took talazoparib alone before surgery for early-stage breast cancer had effective treatment and manageable side effects. Expanded clinical trials are in progress to verify this result. (10/4/19)

XRAYS Rating

STUDY: Inherited mutations In metastatic breast cancer patients

Recent research shows that a significant portion of patients with metastatic breast cancer have harmful mutations in a gene associated with hereditary breast cancer and increased breast cancer risk. (9/26/19)

XRAYS Rating

GUIDELINE: FDA issues warning on CDK inhibitors

The U.S. Food and Drug Administration issued a safety alert for CDK inhibitors, including Ibrance (palbociclib), Kisqali (ribociclib), and Verzenio (abemaciclib). (9/24/19)

XRAYS Rating

STUDY: Does eating meat affect breast cancer risk?

Eating meat has been suggested to increase breast cancer risk. The recent Sister Study looked at meat type, cooking methods and breast cancer risk in a study of 42,012 women.  (9/10/19)

XRAYS Rating

STUDY: Is it safe for BRCA mutation carriers to become pregnant following breast cancer?

New research shows that pregnancy after breast cancer is safe for women with BRCA mutations and their babies. (9/4/19)

FORCE:Facing Our Risk of Cancer Empowered